Gestational choriocarcinoma

Gestational choriocarcinoma is a rare, fast-growing malignancy that typically arises from the trophoblastic tissue, which forms part of the placenta during pregnancy. This type of cancer is a form of gestational trophoblastic disease (GTD) and is characterized by its aggressive nature and potential to metastasize to other parts of the body, including the lungs, liver, and brain. Despite its aggressive nature, gestational choriocarcinoma is highly responsive to chemotherapy, making early diagnosis and treatment crucial for a favorable outcome.

Etiology and Pathogenesis

Gestational choriocarcinoma can develop after any type of pregnancy, but it is most commonly associated with a complete hydatidiform mole, a type of GTD. Other precursors include partial moles, miscarriage, ectopic pregnancy, or even a normal term pregnancy. The transformation of the trophoblastic tissue into cancerous cells is not fully understood, but genetic and environmental factors may play a role.

Clinical Presentation

The symptoms of gestational choriocarcinoma can vary widely but often include vaginal bleeding not associated with menstruation, an enlarged uterus disproportionate to the gestational age of a recent pregnancy, and elevated levels of the pregnancy hormone human chorionic gonadotropin (hCG). In cases where the cancer has metastasized, symptoms may relate to the affected organ, such as coughing or difficulty breathing (lungs), jaundice (liver), or neurological symptoms (brain).

Diagnosis

Diagnosis of gestational choriocarcinoma involves a combination of clinical examination, ultrasound imaging to detect abnormalities in the uterus, and blood tests to measure levels of hCG. High levels of hCG post-pregnancy can be a key indicator of the presence of trophoblastic disease. In some cases, a biopsy of the tissue may be necessary to confirm the diagnosis.

Treatment

The primary treatment for gestational choriocarcinoma is chemotherapy, which can be highly effective. Treatment regimens often involve multiple chemotherapy agents and depend on the stage of the disease and whether it has spread to other parts of the body. Surgery may be required to remove the tumor or affected tissue, particularly in cases where the cancer is resistant to chemotherapy or as a means to control bleeding.

Prognosis

The prognosis for gestational choriocarcinoma is generally good, especially when diagnosed early and treated promptly. The high responsiveness of the cancer to chemotherapy often results in complete remission. However, regular follow-up is essential to monitor for any signs of recurrence.

Prevention and Screening

There are no specific measures to prevent gestational choriocarcinoma. However, early detection of precursors, such as hydatidiform mole, through routine prenatal care and prompt treatment can reduce the risk of developing the cancer. Women who have had a molar pregnancy or other GTD are advised to undergo regular monitoring of hCG levels for an extended period following treatment.

See Also

• Gestational trophoblastic disease
• Hydatidiform mole
• Chemotherapy
• Human chorionic gonadotropin

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian